Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Protein Expression
100%
Trial Design
100%
Molecular Analysis
100%
Therapy Choice
100%
NCI-MATCH
100%
Histology
66%
Interim Analysis
66%
Tumor Biopsy
66%
Tumor
33%
Gene Expression
33%
Transcriptional Repressor
33%
Molecular Alterations
33%
National Cancer Institute
33%
Phosphatase
33%
Treatment Options
33%
National Network
33%
Molecular Targets
33%
Central Tumor
33%
MLH1
33%
Mutation Frequency
33%
Targeted Sequencing
33%
Tensin Homolog
33%
Accruals
33%
Screening Approach
33%
Cancer Research
33%
MutS Homolog 2
33%
Computational Platform
33%
Severe Events
33%
Treatment Eligibility
33%
Tumor Profiling
33%
Refractory Malignancy
33%
Proportion of Tumour
33%
Cancer Histology
33%
Trial Development
33%
Met Expectations
33%
Eligibility Rates
33%
Next Generation DNA
33%
Target Prevalence
33%
Sequencing Assays
33%
Easily Accessible
33%
Molecular Drivers
33%
Enrollment Rate
33%
Accrual Rate
33%
Actionable Molecular Alterations
33%
Medicine and Dentistry
Histology
100%
Genetics
100%
Neoplasm
66%
Malignant Neoplasm
66%
Protein Expression
66%
Tumor Biopsy
66%
Interim Analysis
66%
Gene Expression
33%
Prevalence
33%
Cancer
33%
Targeted Therapy
33%
Phosphatase
33%
Cancer Research
33%
Tumor
33%
DNA Mismatch Repair Protein MSH2
33%
Electrocorticography
33%
Tensin
33%
Mutation Rate
33%
Treatment Option
33%
Biochemistry, Genetics and Molecular Biology
Protein Expression
100%
Genomics
100%
Prevalence
50%
Sample Size
50%
Gene Expression
50%
Mutation Rate
50%
Corepressor
50%
Tensin
50%
Electrocorticography
50%
Phosphatase
50%